Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer.

Li J, O'Malley M, Urban J, Sampath P, Guo ZS, Kalinski P, Thorne SH, Bartlett DL.

Mol Ther. 2011 Apr;19(4):650-7. doi: 10.1038/mt.2010.312. Epub 2011 Jan 25.

2.

Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594.

Breitbach CJ, Thorne SH, Bell JC, Kirn DH.

Curr Pharm Biotechnol. 2012 Jul;13(9):1768-72. Review.

PMID:
21740365
3.

The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?

Thorne SH, Bartlett DL, Kirn DH.

Curr Gene Ther. 2005 Aug;5(4):429-43. Review.

PMID:
16101516
4.

Replicating poxviruses for human cancer therapy.

Kim M.

J Microbiol. 2015 Apr;53(4):209-18. doi: 10.1007/s12275-015-5041-4. Epub 2015 Apr 8. Review.

PMID:
25845536
5.

Immunotherapeutic potential of oncolytic vaccinia virus.

Thorne SH.

Immunol Res. 2011 Aug;50(2-3):286-93. doi: 10.1007/s12026-011-8211-4. Review.

PMID:
21717084
6.

The mechanisms of genetically modified vaccinia viruses for the treatment of cancer.

Jefferson A, Cadet VE, Hielscher A.

Crit Rev Oncol Hematol. 2015 Sep;95(3):407-16. doi: 10.1016/j.critrevonc.2015.04.001. Epub 2015 Apr 13. Review.

PMID:
25900073
7.

Vaccinia virus and oncolytic virotherapy of cancer.

Thorne SH, Hwang TH, Kirn DH.

Curr Opin Mol Ther. 2005 Aug;7(4):359-65. Review.

PMID:
16121702
8.

Immunotherapeutic potential of oncolytic vaccinia virus.

Thorne SH.

Front Oncol. 2014 Jun 17;4:155. doi: 10.3389/fonc.2014.00155. eCollection 2014. Review.

9.

Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy.

Sampath P, Thorne SH.

Oncolytic Virother. 2015 Jun 18;4:75-82. doi: 10.2147/OV.S54738. eCollection 2015. Review.

10.

Oncolytic virus expressing RANTES and IL-15 enhances function of CAR-modified T cells in solid tumors.

Nishio N, Dotti G.

Oncoimmunology. 2015 Mar 6;4(2):e988098. eCollection 2015 Feb. Review.

Supplemental Content

Support Center